Skip to main content

Medical Code Search: "History of COVID-19"

Results for “History of COVID-19” from ICD-10-CM, HCPCS Level II and ICD-10-PCS. Code titles and billable status are read from the published releases.

What MedCoder understood

You searched
History of COVID-19
MedCoder understood
COVID-19, history of
Search type
Diagnosis / condition
Primary registry
ICD-10-CM
  • Understood as a diagnosis or condition search, so ICD-10-CM is ranked first.
  • covid-19 → COVID-19

Best matches

Z86.16Personal history of COVID-19
ICD-10-CMBillable

Under Z86 Personal history of certain other diseases

Index / inclusion term · Alphabetic Index: COVID-19, history of

Why this matched
  • Matched through the ICD-10-CM Alphabetic Index: “COVID-19, history of”
  • Sits under Z86 Personal history of certain other diseases in the ICD-10-CM tabular.
  • The tabular carries it at billable code level.

Explore Z86.16

Z86.16 Personal history of COVID-19 — what its code page carries, from the official tables.

Index terms10Referenced by other codes3Coding guides1CCSR clinical group1· Personal history of other diseaseMS-DRG1NCD-covered lab tests1Code history1CompareClaim Check

ICD-10-CM

Its one match is shown above under Best matches.

HCPCS Level II: 4 matches

Show HCPCS Level II results 4 related results
Q0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
HCPCS Level IIRemoved
Q0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
HCPCS Level IIRemoved
M0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring
HCPCS Level IIRemoved
M0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
HCPCS Level IIRemoved

ICD-10-PCS: 10 matches

See all in ICD-10-PCS →

4 of them are shown above under Best matches.

Show ICD-10-PCS results 10 related results
XW023V7Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7
ICD-10-PCS
XW023W7Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7
ICD-10-PCS
XW013S6Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
ICD-10-PCS
XW013T6Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
ICD-10-PCS